COVANCE INC
10-Q, EX-27, 2000-07-28
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: COVANCE INC, 10-Q, EX-10.C, 2000-07-28
Next: HOUSEHOLD REVOLVING HOME EQUITY LOAN TRUST 1996-2, 8-K, 2000-07-28



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     This schedule contains summary financial information extracted from the
     Covance consolidated financial statements for the six months ended June
     30, 2000 and is qualified in its entirety by reference to such financial
     statements.
</LEGEND>
<CIK>                         0001023131
<NAME>                        Covance Inc.
<MULTIPLIER>                                             1
<CURRENCY>                                             USD

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                          1
<CASH>                                          14,217,000
<SECURITIES>                                             0
<RECEIVABLES>                                  230,755,000
<ALLOWANCES>                                             0
<INVENTORY>                                     27,575,000
<CURRENT-ASSETS>                               344,187,000
<PP&E>                                         557,453,000
<DEPRECIATION>                                 247,735,000
<TOTAL-ASSETS>                                 759,447,000
<CURRENT-LIABILITIES>                          216,972,000
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                           593,000
<OTHER-SE>                                     270,259,000
<TOTAL-LIABILITY-AND-EQUITY>                   759,447,000
<SALES>                                                  0
<TOTAL-REVENUES>                               421,745,000
<CGS>                                          298,458,000
<TOTAL-COSTS>                                  404,275,000
<OTHER-EXPENSES>                                  (136,000)
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                               6,368,000
<INCOME-PRETAX>                                 11,238,000
<INCOME-TAX>                                     4,343,000
<INCOME-CONTINUING>                              6,895,000
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                     6,895,000
<EPS-BASIC>                                           0.12
<EPS-DILUTED>                                         0.12


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission